The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...
Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...
Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...
Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...
The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...
The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set to retire just weeks after taking the ...
The nation’s top drug regulator, Richard Pazdur, has decided to retire three weeks after taking the job, according to two people familiar with his decision who spoke on the condition of anonymity to ...
Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...
Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...
Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...
Dec 2 (Reuters) - The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback